Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Current Leases (2019 - 2026)

Nutex Health (NUTX) has disclosed Current Leases for 8 consecutive years, with $7.4 million as the latest value for Q1 2026.

  • For Q1 2026, Current Leases fell 8.26% year-over-year to $7.4 million; the TTM value through Mar 2026 reached $7.4 million, down 8.26%, while the annual FY2025 figure was $2.2 million, 3.46% up from the prior year.
  • Current Leases hit $7.4 million in Q1 2026 for Nutex Health, up from $2.2 million in the prior quarter.
  • Across five years, Current Leases topped out at $8.0 million in Q1 2025 and bottomed at $47773.0 in Q1 2022.
  • Average Current Leases over 5 years is $3.6 million, with a median of $3.6 million recorded in 2022.
  • Year-over-year, Current Leases skyrocketed 8008.3% in 2022 and then crashed 51.81% in 2024.
  • Nutex Health's Current Leases stood at $1.7 million in 2022, then skyrocketed by 153.43% to $4.3 million in 2023, then plummeted by 51.81% to $2.1 million in 2024, then increased by 3.46% to $2.2 million in 2025, then soared by 242.19% to $7.4 million in 2026.
  • According to Business Quant data, Current Leases over the past three periods came in at $7.4 million, $2.2 million, and $7.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.